CXCR4-positive subset of glioma is enriched for cancer stem cells

Oncology Research

Volumn 19, Issue 12, 2012, Pages 555-561

  Zheng, Xuesheng ^a   Xie, QingSong ^b   Li, Shiting ^a   Zhang, Wenchuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Cixi Municipal People's Hospital   (China)

Author keywords

Cancer stem cell; CXC chemokine receptor 4 (CXCR4); Glioma

Indexed keywords

CD133 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CXCR4; TEMOZOLOMIDE;

AGAR MEDIUM; ARTICLE; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL RENEWAL; CELL SELECTION; CELL SUBPOPULATION; CXCR4+ GLIOMA CELL; CXCR4- GLIOMA CELL; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MULTIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

EID: 84861774808     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504012X13340632812631     Document Type: Article

References (31)

1. Fomchenko, E. I.; Holland, E. C. Stem cells and brain cancer. Exp Cell Res. 306:323-329; 2005.
2. Kondo, T. Brain cancer stem-like cells. Eur. J. Cancer 42:1237-1242; 2006.
3. Dirks, P. B. Brain tumour stem cells: The undercurrents of human brain cancer and their relationship to neural stem cells. Philos. Trans. R Soc. Lond. B Biol. Sci. 363:139-152; 2008.
4. Heddleston, J. M.; Hitomi, M.; Venere, M.; Flavahan, W. A.; Yang, K.; Kim, Y.; Minhas, S.; Rich, J. N.; Hjelmeland, A. B. Glioma stem cell maintenance: The role of the microenvironment. Curr. Pharm. Des. 17:2386-2401; 2011.
5. Holmberg, J.; He, X.; Peredo, I.; Orrego, A.; Hesselager, G.; Ericsson, C.; Hovatta, O.; Oba-Shinjo, S. M.; Marie, S. K.; Nister, M.; Muhr, J. Activation of neural and pluri- potent stem cell signatures correlates with increased malignancy in human glioma. PLoS One 6:e18454; 2011.
6. Zhu, W. Z.; Li, X.; Qi, J. P.; Tang, Z. P.; Wang, W.; Wei, L.; Lei, H. Experimental study of cell migration and functional differentiation of transplanted neural stem cells co-labeled with superparamagnetic iron oxide and BrdU in an ischemic rat model. Biomed. Environ. Sci. 21:420-424; 2008.
7. Flexman, J. A.; Cross, D. J.; Kim, Y.; Minoshima, S. Morphological and parametric estimation of fetal neural stem cell migratory capacity in the rat brain. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007:4464-4467; 2007.
8. Heese, O.; Disko, A.; Zirkel, D.; Westphal, M.; Lamszus, K. Neural stem cell migration toward gliomas in vitro. Neuro Oncol. 7:476-484; 2005.
9. Zhao, D.; Najbauer, J.; Garcia, E.; Metz, M. Z.; Gutova, M.; Glackin, C. A.; Kim, S. U.; Aboody, K. S. Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol. Cancer Res. 6:1819-1829; 2008.
10. Frosina, G. Stem cell-mediated delivery of therapies in the treatment of glioma. Mini Rev. Med. Chem. 11:591-598; 2011.
11. Li, S.; Gao, Y.; Tokuyama, T.; Yamamoto, J.; Yokota, N.; Yamamoto, S.; Terakawa, S.; Kitagawa, M.; Namba, H. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett. 251:220-227; 2007.
12. Imitola, J.; Raddassi, K.; Park, K. I.; Mueller, F. J.; Nieto, M.; Teng, Y. D.; Frenkel, D.; Li, J.; Sidman, R. L.; Walsh, C. A.; Snyder, E. Y.; Khoury, S. J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101:18117-18122; 2004.
13. Hartman, N. W.; Carpentino, J. E.; LaMonica, K.; Mor, D. E.; Naegele, J. R.; Grabel, L. CXCL12-mediated guidance of migrating embryonic stem cell-derived neural progenitors transplanted into the hippocampus. PLoS One 5:e15856; 2010.
14. Schulte, A.; Gunther, H. S.; Phillips, H. S.; Kemming, D.; Martens, T.; Kharbanda, S.; Soriano, R. H.; Modrusan, Z.; Zapf, S.; Westphal, M.; Lamszus, K. A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target. Glia 59:590-602; 2011.
15. Zhou, Y.; Larsen, P. H.; Hao, C.; Yong, V. W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J. Biol. Chem. 277:49481-49487; 2002.
16. Bajetto, A.; Barbieri, F.; Dorcaratto, A.; Barbero, S.; Daga, A.; Porcile, C.; Ravetti, J. L.; Zona, G.; Spaziante, R.; Corte, G.; Schettini, G.; Florio, T. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem. Int. 49:423-432; 2006.
17. Ping, Y. F.; Yao, X. H.; Jiang, J. Y.; Zhao, L. T.; Yu, S. C.; Jiang, T.; Lin, M. C.; Chen, J. H.; Wang, B.; Zhang, R.; Cui, Y. H.; Qian, C.; Wang, J.; Bian, X. W. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J. Pathol. 224:344-354; 2011.
18. Yang, S. X.; Chen, J. H.; Jiang, X. F.; Wang, Q. L.; Chen, Z. Q.; Zhao, W.; Feng, Y. H.; Xin, R.; Shi, J. Q.; Bian, X. W. Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem. Biophys. Res. Commun. 335:523-528; 2005.
19. Hong, X.; Jiang, F.; Kalkanis, S. N.; Zhang, Z. G.; Zhang, X. P.; DeCarvalho, A. C.; Katakowski, M.; Bobbitt, K.; Mikkelsen, T.; Chopp, M. SDF-1 and CXCR4 are upregulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 236:39-45; 2006.
20. Tu, H.; Zhou, Z.; Liang, Q.; Li, Z.; Li, D.; Qing, J.; Wang, H.; Zhang, L. CXCR4 and SDF-1 production are stimulated by hepatocyte growth factor and promote glioma cell invasion. Onkologie 32:331-336; 2009.
21. Ehtesham, M.; Winston, J. A.; Kabos, P.; Thompson, R. C. CXCR4 expression mediates glioma cell invasiveness. Oncogene 25:2801-2806; 2006.
22. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D. L.; Black, K. L.; Yu, J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400; 2004.
23. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011-7021; 2004.
24. Hemmati, H. D.; Nakano, I.; Lazareff, J. A.; Masterman-Smith, M.; Geschwind, D. H.; Bronner-Fraser, M.; Kornblum, H. I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 100:15178-15183; 2003.
25. Charles, N.; Holland, E. C. Brain tumor treatment increases the number of cancer stem-like cells. Expert Rev. Neurother. 9:1447-1449; 2009.
26. Dirks, P. B. Cancer: Stem cells and brain tumours. Nature 444:687-688; 2006.
27. Bao, S.; Wu, Q.; McLendon, R. E.; Hao, Y.; Shi, Q.; Hjelmeland, A. B.; Dewhirst, M. W.; Bigner, D. D.; Rich, J. N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760; 2006.
28. Donnenberg, V. S.; Donnenberg, A. D. Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis. J. Clin. Pharmacol. 45:872-877; 2005.
29. Zeppernick, F.; Ahmadi, R.; Campos, B.; Dictus, C.; Helmke, B. M.; Becker, N.; Lichter, P.; Unterberg, A.; Radlwimmer, B.; Herold-Mende, C. C. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 14:123-129; 2008.
30. Zhang, M.; Song, T.; Yang, L.; Chen, R.; Wu, L.; Yang, Z.; Fang, J. Nestin and CD133: Valuable stem cellspecific markers for determining clinical outcome of glioma patients. J. Exp. Clin. Cancer Res. 27:85; 2008.
31. Wang, J.; Sakariassen, P. O.; Tsinkalovsky, O.; Immervoll, H.; Boe, S. O.; Svendsen, A.; Prestegarden, L.; Rosland, G.; Thorsen, F.; Stuhr, L.; Molven, A.; Bjerkvig, R.; Enger, P. O. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int. J. Cancer 122:761-768; 2008.